Medical researchers evaluated females with recurrent Major Depressive Disorder (MDD) that were on dopamine antidepressant regimens. Half of the subjects received Low Dose Naltrexone and the other half received a placebo.
LDN improved depression symptoms better than placebo in just 3 weeks, in all 5 of the depression assessments. In summary, the researchers found LDN further improved dopamine therapy prescriptions for depression in people with Major Depressive Disorder.
Low Dose Naltrexone requires a prescription from your healthcare provider and is available as a custom compounded prescription. If you live in Oklahoma and your healthcare provider doesn’t prescribe LDN get in touch with Flourish Compounding Pharmacy. We have a list of LDN prescribing practitioners.
Please share this information with a loved one struggling with Major Depressive Disorder (MDD).
David Mischoulon, Lindsay Hylek, Albert S. Yeung, et al. Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants, Journal of Affective Disorders, Volume 208, 2017, Pages 6-14, ISSN 0165-0327, https://doi.org/10.1016/j.jad.2016.08.029.
This information is for educational purposes. Check with your healthcare provider before making changes in your health program.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. The information in the Feel Better blog is for informational purposes only. Always consult with your healthcare provider before making any changes to your health program.
